NCT06330350 Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
| NCT ID | NCT06330350 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Maastricht University Medical Center |
| Condition | Quality of Life |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2025-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2024-01-01 with a primary completion date of 2025-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to understand the perspectives and needs of patients with genodermatoses and their partners who wish to have children, regarding their decision-making process and their consideration of reproductive options. Additionally, the investigators aim to investigate the level of knowledge and perspectives of healthcare professionals (such as clinical geneticists, dermatologists and other clinicians involved), and want to explore to what extent patients and their partners are well informed about these reproductive options. To achieve this, the investigators will conduct individual semi-structured qualitative interviews with participants affected by genodermatoses (and their partners) and with healthcare professionals.
Eligibility Criteria
Inclusion Criteria: * Adult patients with genodermatosis (i.e, keratinisation disorders, skin fragility diseases, ectodermal dysplasias, dermato-oncological syndromes, other genodermatoses) and a desire to have children, with if applicable his or her partner with a desire to have children * Patients with clinically and molecularly confirmed variant of a genodermatosis * Health care professionals involved with the care of genodermatology patients (e.g. clinical geneticists, dermatologists) Exclusion Criteria: * Not being able to communicate verbally in Dutch or English
Contact & Investigator
Antoni Gostynski, MD, PhD
PRINCIPAL INVESTIGATOR
Maastricht University Medical Center
Frequently Asked Questions
Who can join the NCT06330350 clinical trial?
This trial is open to participants of all sexes, studying Quality of Life. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06330350 currently recruiting?
Yes, NCT06330350 is actively recruiting participants. Contact the research team at genodermatose@mumc.nl for enrollment information.
Where is the NCT06330350 trial being conducted?
This trial is being conducted at Maastricht, Netherlands.
Who is sponsoring the NCT06330350 clinical trial?
NCT06330350 is sponsored by Maastricht University Medical Center. The principal investigator is Antoni Gostynski, MD, PhD at Maastricht University Medical Center. The trial plans to enroll 25 participants.